Geranylhydroquinone



Compound IDCDAMM01398
Common nameGeranylhydroquinone
IUPAC name2-(3,7-dimethylocta-2,6-dienyl)benzene-1,4-diol
Molecular formulaC16H22O2

Experimental data

Retention time10.07
Adduct[M+K]+
Actual mz285.122
Theoretical mz285.125
Error9.32
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.8968

Identifiers and class information

Inchi keyZSCRTFONTNMQBL-NTUHNPAUSA-N
SmilesOC1=CC=C(O)C(=C1)CC=C(C)CCC=C(C)C
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)7
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)0
Molecular weight (mol_MW)246.349
Computed dipole moment(dipole)2.553
Total solvent accessible surface area (SASA)522.255
Hydrophobic component of SASA (FOSA)315.853
Hydrophilic component of SASA (FISA)74.275
Pie component of the SASA (PISA)132.127
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)924.42
Number of hydrogen bond donors (donorHB)2
Number of hydrogen bond acceptors (accptHB)1.5
Free energy of solvation of dipole (dip^2/V)0.0070502
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0040618
Globularity descriptor (glob)0.878742
Predicted polarizability in cubic angstroms (QPpolrz)27.608
Predicted hexadecane/gas partition coefficient (QPlogPC16)8.804
Predicted octanol/gas partition coefficient (QPlogPoct)12.219
Predicted water/gas partition coefficient (QPlogPw)5.243
Predicted octanol/water partition coefficient (QPlogPo/w)3.817
Predicted aqueous solubility (QPlogS)-3.792
Conformation-independent predicted aqueous solubility (CIQPlogS)-3.767
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.124
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1956.83
Predicted brain/blood partition coefficient (QPlogBB)-0.5
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)1022.08
Predicted skin permeability, log Kp (QPlogKp)-1.751
PM3 calculated ionization potential (IP(ev))8.683
PM3 calculated electron affinity (EA(eV))-0.161
Number of likely metabolic reactions (#metab)8
Prediction of binding to human serum albumin (QPlogKhsa)0.41
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)42.943
Number of nitrogen and oxygen atoms (#NandO)2
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P18031PTPN1Protein-tyrosine phosphatase 1BT16347SEA
P09917ALOX5Arachidonate 5-lipoxygenaseT00140SwissTargetPrediction
Q14534SQLESqualene monooxygenase (by homology)T93344SEA
P16050ALOX15Arachidonate 15-lipoxygenaseT16042SwissTargetPrediction
P14679TYRTyrosinaseT97035SEA
P30307CDC25CDual specificity phosphatase Cdc25CT40569SEA
O95749GGPS1GeranyltranstransferaseT86528SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16347DI0009Acute diabete complication[ICD-11: 5A2Y]P18031PTPN1
T16347DI0062Breast cancer[ICD-11: 2C60-2C6Y]P18031PTPN1
T16347DI0308Obesity[ICD-11: 5B80-5B81]P18031PTPN1
T16347DI0417Type 2 diabetes mellitus[ICD-11: 5A11]P18031PTPN1
T00140DI0037Asthma[ICD-11: CA23]P09917ALOX5
T00140DI0147Filariasis[ICD-11: 1F66]P09917ALOX5
T00140DI0403Thrombocytopenia[ICD-11: 3B64]P09917ALOX5
T93344DI0118Dermatophytosis[ICD-11: 1F28]Q14534SQLE
T93344DI0385Skin fungal infection disorder[ICD-11: EA60]Q14534SQLE
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T86528DI0057Bone paget disease[ICD-11: FB85]O95749GGPS1
T86528DI0237Low bone mass disorder[ICD-11: FB83]O95749GGPS1
T86528DI0267Mineral excesses[ICD-11: 5B91]O95749GGPS1
T86528DI0281Musculoskeletal disorder[ICD-11: FA00-FC0Z]O95749GGPS1

Copyright © 2025